Skip to main content
Defiance International

Thymosin Beta 4 protects mice from monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.

In vivo/preclinical record. PloS one, 2014.

  • Animal
  • 2014

Authorship

Exact sentences from the abstract. No machine-written text is on this page. No person reviewed it.

Source: the abstract of PMID 25412097. Checked Verification: Evidence verified by machine against declared source

This study and its findings belong to the authors cited. Defiance International, a supplier of chemical sequences for research use, keeps this record and makes no claim from its findings.

Verify a lot

Evidence verified by machine against declared source

Open declared source

Key facts

Design
Not reported
System
Animal
Scale
A total of six mice were studied in each group.
Comparator
Present
Journal
PloS one
Year
2014
PMID
25412097
Verification
Evidence verified by machine against declared source The stored extraction was checked against its declared source. Public summary availability is separate. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.
Full-text availability
Abstract only

Technical summary

Research question

The purpose of this study is to evaluate the whether Tβ4 can be used as a vascular-protective agent.

Study design

To corroborate the in vivo studies, we performed our analysis using lung microvascular endothelial cells (MVEC) stimulated with TGFβ1.

Participants or experimental system

Twelve-week-old male mice (∼25 g) were used for experiments.

Study scale

A total of six mice were studied in each group.

Intervention or exposure

Briefly, wild-type (WT) mice received an intraperitoneal (i.p) injection of MCT (80 mg/kg body wt) every 20 days for 3 times.

Comparator

Age- and sex-matched WT with normal saline-injected mice of C57BL/6 background served as controls.

Outcomes examined

The pathogenesis of MCT-induced PH was evaluated through RV pressure measurement.

Key findings

In monocrotaline (MCT)-induced PH mouse model, we showed that mice treated with Tβ4 significantly attenuated the systolic pressure and RVH, compared to the MCT treated mice.

Not reported in the declared source: Methods.

Limitations and uncertainty

Not reported in the declared source.

Cite

Cite the study

Thymosin Beta 4 protects mice from monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
Wei C, Kim IK, Li L et al. PloS one. 2014. PMID 25412097

The study and its abstract belong to their authors and publisher. Cite them for anything the study found.

Report an error

If a sentence on this record does not match the abstract, tell us which one. A report starts an automatic re-check by machine. No person reads the record first.

The form takes a sentence and your note. It asks for no name and no address, and we store neither. Do not put personal details in the note.

The report form runs in the interactive page. Open this record with scripts enabled to send a report.

Corrections on this record

No correction has been recorded for this record.

Method sheet

No machine-drafted summary is published on this record. Any section shown is the abstract’s own sentence, printed as issued.